India · Delayed Price · Currency is INR Emcure Pharmaceuticals Statistics
Total Valuation
NSE:EMCURE has a market cap or net worth of INR 256.65 billion. The enterprise value is 266.52 billion.
| Market Cap | 256.65B |
| Enterprise Value | 266.52B |
Important Dates
The next estimated earnings date is Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
NSE:EMCURE has 189.51 million shares outstanding. The number of shares has increased by 4.50% in one year.
| Current Share Class | 189.51M |
| Shares Outstanding | 189.51M |
| Shares Change (YoY) | +4.50% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 72.83% |
| Owned by Institutions (%) | 3.91% |
| Float | 20.55M |
Valuation Ratios
The trailing PE ratio is 34.41 and the forward PE ratio is 25.61. NSE:EMCURE's PEG ratio is 0.99.
| PE Ratio | 34.41 |
| Forward PE | 25.61 |
| PS Ratio | 3.14 |
| PB Ratio | 5.53 |
| P/TBV Ratio | 7.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.99 |
Enterprise Valuation
| EV / Earnings | 35.81 |
| EV / Sales | 3.26 |
| EV / EBITDA | 17.34 |
| EV / EBIT | 23.25 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 0.67 |
| Debt / FCF | n/a |
| Interest Coverage | 11.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 12.89% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 12.15M |
| Profits Per Employee | 1.11M |
| Employee Count | 6,731 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:EMCURE has paid 2.85 billion in taxes.
| Income Tax | 2.85B |
| Effective Tax Rate | 27.02% |
Stock Price Statistics
The stock price has decreased by -2.68% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -2.68% |
| 50-Day Moving Average | 1,379.88 |
| 200-Day Moving Average | 1,244.65 |
| Relative Strength Index (RSI) | 42.14 |
| Average Volume (20 Days) | 141,037 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:EMCURE had revenue of INR 81.81 billion and earned 7.44 billion in profits. Earnings per share was 39.35.
| Revenue | 81.81B |
| Gross Profit | 48.40B |
| Operating Income | 11.46B |
| Pretax Income | 10.55B |
| Net Income | 7.44B |
| EBITDA | 14.90B |
| EBIT | 11.46B |
| Earnings Per Share (EPS) | 39.35 |
Balance Sheet
The company has 2.32 billion in cash and 10.23 billion in debt, giving a net cash position of -7.91 billion or -41.75 per share.
| Cash & Cash Equivalents | 2.32B |
| Total Debt | 10.23B |
| Net Cash | -7.91B |
| Net Cash Per Share | -41.75 |
| Equity (Book Value) | 46.42B |
| Book Value Per Share | 234.65 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 59.16%, with operating and profit margins of 14.01% and 9.10%.
| Gross Margin | 59.16% |
| Operating Margin | 14.01% |
| Pretax Margin | 12.89% |
| Profit Margin | 9.10% |
| EBITDA Margin | 18.21% |
| EBIT Margin | 14.01% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.22%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 0.22% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.50% |
| Shareholder Yield | -4.28% |
| Earnings Yield | 2.90% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |